ArticleCells2021

Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.

Tonino Alonzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.